These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4141934)

  • 1. Immunosuppressive activity of serum during the development of experimental allergic encephalomyelitis.
    Vandenbark AA; Gibbins BL; Hinrichs DJ
    Cell Immunol; 1974 Mar; 11(1-3):1-10. PubMed ID: 4141934
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
    Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
    Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
    Englert D; Hempel K
    Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM; Swierkosz JE; Swanborg RH
    J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed leukocyte reaction in rabbits with experimental autoimmune encephalomyelitis.
    Lindh J
    Scand J Immunol; 1973; 2(4):417-23. PubMed ID: 4129418
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular transfer of experimental allergic encephalomyelitis in Lewis rats: effects of different sensitization regimens on in vitro reactivity of donor spleen cells to concanavalin A.
    Ovadia H; Paterson PY
    Cell Immunol; 1981 Nov; 65(1):66-74. PubMed ID: 6172201
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis.
    Webb C; Teitelbaum D; Arnon R; Sela M
    Eur J Immunol; 1973 May; 3(5):279-86. PubMed ID: 4128128
    [No Abstract]   [Full Text] [Related]  

  • 10. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis.
    Hinrichs DJ; Humphres RC
    J Immunol; 1983 Jul; 131(1):4-5. PubMed ID: 6190918
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental allergic encephalomyelitis in the guinea pig: variation in peripheral blood lymphocyte responsiveness to myelin basic protein during disease development.
    Lyman WD; Kadish AS; Raine CS
    Cell Immunol; 1981 Sep; 63(2):409-16. PubMed ID: 6168397
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on lymphocyte transformation in experimental allergic encephalomyelitis.
    Warnatz H; Scheiffarth F; Kuntz H
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):575-82. PubMed ID: 5471922
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of recovery and acquired resistance in Lewis rat experimental allergic encephalomyelitis.
    Willenborg DO
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):125-34. PubMed ID: 6167252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Freund's adjuvants (CFA) induced unresponsiveness to EAE in Lewis rats.
    Hempel K; Freitag A; Freitag B; Endres B; Mai B
    Prog Clin Biol Res; 1984; 146():407-14. PubMed ID: 6201910
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of macrophage inhibition factor by rat lymphocytes following exposure to isologous liver subcellular membranes.
    McCalmon RT; Pinckard RN; Olson MS
    Clin Immunol Immunopathol; 1975 Mar; 3(4):541-54. PubMed ID: 163716
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of heparin and protamine on enlargement of the draining lymph node during induction of EAE.
    Matous-Malbohan I; Arnason BG
    Cell Immunol; 1974 Jun; 12(3):345-9. PubMed ID: 4142421
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.